Analysis of the immunological microenvironment at the tumor site in patients with non-small cell lung cancer
- 19 September 2003
- journal article
- research article
- Published by Springer Nature in Langenbecks Archives Of Surgery
- Vol. 388 (6) , 406-412
- https://doi.org/10.1007/s00423-003-0416-0
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- IL-12-induced production of IL-10 and interferon-γ by mononuclear cells in lung cancer-associated malignant pleural effusionsLung Cancer, 2002
- Cytokine secretion: clinical relevance of immunosuppression in non-small cell lung cancerLung Cancer, 2001
- Clinical implications of interleukin (IL)-10 induced by non-small-cell lung cancerAnnals of Oncology, 2000
- Antigen-specific cancer immunotherapy using a GM-CSF secreting allogeneic tumor cell-based vaccineInternational Journal of Cancer, 2000
- Serum Interleukin-10 Levels as a Prognostic Factor in Advanced Non-small Cell Lung Cancer PatientsChest, 2000
- Postoperative adjuvant adoptive immunotherapy with lymph node-LAK cells and IL-2 for pathologic stage I non-small cell lung cancerLung Cancer, 1999
- [The predominant expression of Th2 type cytokines in human tumor cells].1998
- Antitumor effect induced by the expression of granulocyte macrophage-colony stimulating factor gene in murine colon carcinoma cellsCancer Letters, 1996
- T Cell Recognition of Human Tumors: Implications for Molecular Immunotherapy of CancerClinical Immunology and Immunopathology, 1993
- A highly immunogenic tumor transfected with a murine transforming growth factor type beta 1 cDNA escapes immune surveillance.Proceedings of the National Academy of Sciences, 1990